Our Team - CureLogic

CURELOGIC

PROFESSIONAL TEAM

Gwen Swan is a philosopher, mathematician, and strategist exploring AI, human rights, and decentralized governance.

As the founder and CEO of CureLogic Ltd., IPPON FinTech, and FFA Ventures, Gwen has led pioneering efforts in biotechnology, IP asset securitization, and startup acceleration across global markets. Her thought leadership spans technological innovation, legal theory, and ethical design, driven by a lifelong commitment to equity, intelligence, and human dignity.

Gwen Swan

CEO

Professor Krams holds a Chair in Molecular Bioengineering at Imperial College, London.

Professor Krams was trained at the Free University Amsterdam, where he did his PhD. After two years in the USA, he joined the Bioengineering team of the Thorax centre in Rotterdam. He was a recipient of an Established Investigator (2003-2008). He joined Imperial College London in 2007, where he was a full professor in Bioengineering. In 2018 he joined Qmul as a professor in Bioengineering. he is associate editor of 12 journals and written >500 papers.

Rob Krams

CSO

Advisory Board

Meet the People Behind the Breakthroughs

CureLogic is driven by a leadership team with a proven track record in medical science, AI research, and organizational excellence. Our board and operational members ensure that every initiative is executed with precision, impact, and integrity.